✉news WorldEU Politics first seen 3 d ago, last 3 d ago, peak #19
Pancreatic cancer drug cuts death risk by 60% in trial
Original: A pancreatic cancer drug cut the risk of death by 60% versus chemotherapy in a trial.
A new pancreatic cancer drug reduced the risk of death by 60% compared with standard chemotherapy in a clinical trial, a major result for one of the hardest-to-treat cancers. Pancreatic cancer has among the lowest survival rates, so any substantial improvement over chemotherapy draws wide attention from patients, doctors and researchers.
Why now: A large survival benefit in pancreatic cancer, a disease with very poor prognosis, is rare and highly newsworthy.
pancreatic cancerchemotherapyclinical trial
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2367253